Comparison of partitioned survival modeling with state transition modeling approaches with or without consideration of brain metastasis: a case study of Osimertinib versus pemetrexed-platinum

Yoon-Bo Shim,Byeong-Chan Oh,Eui-Kyung Lee,Mi-Hai Park
DOI: https://doi.org/10.1186/s12885-024-11971-x
IF: 4.638
2024-02-11
BMC Cancer
Abstract:The partitioned survival model (PSM) and the state transition model (STM) are widely used in cost-effectiveness analyses of anticancer drugs. Using different modeling approaches with or without consideration of brain metastasis, we compared the quality-adjusted life-year (QALY) estimates of Osimertinib and pemetrexed-platinum in advanced non-small cell lung cancer with epidermal growth factor receptor mutations.
oncology
What problem does this paper attempt to address?